The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Pfizer Inc (NYSE: PFE) closed at $24.94 down -0.64% from its previous closing price of $25.10. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 45.96 million shares were traded. PFE stock price reached its highest trading level at $25.1 during the session, while it also had its lowest trading level at $24.65.
Ratios:
For a deeper understanding of Pfizer Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.18. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on November 15, 2024, initiated with a Underperform rating and assigned the stock a target price of $25.
On October 17, 2024, Bernstein started tracking the stock assigning a Mkt Perform rating and target price of $32.Bernstein initiated its Mkt Perform rating on October 17, 2024, with a $32 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 30 ’24 when Gottlieb Scott bought 1,000 shares for $28.24 per share. The transaction valued at 28,240 led to the insider holds 10,000 shares of the business.
DAMICO JENNIFER B. sold 5,154 shares of PFE for $147,714 on Aug 13 ’24. The SVP & Controller now owns 8,582 shares after completing the transaction at $28.66 per share. On Dec 15 ’23, another insider, Gottlieb Scott, who serves as the Director of the company, bought 3,000 shares for $26.47 each. As a result, the insider paid 79,401 and bolstered with 9,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PFE now has a Market Capitalization of 142241546240 and an Enterprise Value of 199598735360. As of this moment, Pfizer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.53, and their Forward P/E ratio for the next fiscal year is 8.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.35 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 3.362 whereas that against EBITDA is 10.868.
Stock Price History:
Over the past 52 weeks, PFE has reached a high of $31.54, while it has fallen to a 52-week low of $24.48. The 50-Day Moving Average of the stock is -12.06%, while the 200-Day Moving Average is calculated to be -11.31%.
Shares Statistics:
For the past three months, PFE has traded an average of 35.78M shares per day and 59877890 over the past ten days. A total of 5.67B shares are outstanding, with a floating share count of 5.66B. Insiders hold about 0.04% of the company’s shares, while institutions hold 67.53% stake in the company. Shares short for PFE as of 1730332800 were 61869322 with a Short Ratio of 1.73, compared to 1727654400 on 67620137. Therefore, it implies a Short% of Shares Outstanding of 61869322 and a Short% of Float of 1.09.
Dividends & Splits
According to the company, the forward annual dividend rate for PFE is 1.68, from 1.67 in the trailing year. Against a Trailing Annual Dividend Yield of 0.06653386The stock’s 5-year Average Dividend Yield is 4.23.
